![](https://www.mitacs.ca/wp-content/uploads/2023/12/generic-logo-background.png)
Alzheimers disease is the most common neurodegenerative disorder. The recent immunotherapy brings the hope of treating AD as suggested by several preclinical studies. This project first aims to develop a humanized monoclonal antibody to target the molecules involved in generating a toxic protein of AD, named amyloid ?, and test the application of this antibody […]
Read More